Cameroon vs Iraq: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Cameroon
82.0%
in 2025
Iraq
82.0%
in 2025
Cameroon rank
106th
Iraq rank
106th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Cameroon
- Iraq
How they compare
Cameroon currently reports 82.0% against 82.0% in Iraq, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Iraq ahead.
Cameroon ranks 106th and Iraq ranks 106th of 194 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.2% | 10.3% | 51.9% | Cameroon |
| 2020s | 73.7% | 26.8% | 46.8% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Cameroon or Iraq?
- Cameroon, at 82.0% against 82.0% in Iraq as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Cameroon and Iraq?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Iraq?
- 18 years are reported by both, from 2008 to 2025.
- How do Cameroon and Iraq rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Cameroon ranks 106th and Iraq ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.